Full Press Release Details
NEW BRUNSWICK, N.J. , Feb. 7, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the Cowen 42 nd Annual Health Care Virtual Conference on Monday, March 7 th . Mathai Mammen , Executive Vice President, Pharmaceuticals R&D will represent the Company in a session scheduled at 9:10 a.m. (Eastern Time) .
This conference call will be available to investors and other interested parties by visit the Johnson & Johnson website at www.investor.jnj.com .
A webcast and podcast replay will be available approximately 48 hours after the live webcast.